Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914190-15-000080
Filing Date
2015-02-17
Accepted
2015-02-17 16:22:24
Documents
1
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 5  
1 PRIMARY DOCUMENT edgar.xml 5 12053
  Complete submission text file 0000914190-15-000080.txt   13533
Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822 (862) 703-7175
Arno Therapeutics, Inc (Issuer) CIK: 0001195116 (see all company filings)

EIN.: 522286452 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address
Zukiwski Alexander A (Reporting) CIK: 0001569782 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-52153 | Film No.: 15622882